Assertio Holdings Inc. Announces 1‑for‑15 Reverse Stock Split
Assertio Holdings Inc. (NASDAQ: ASRT), a U.S.‑based pharmaceutical company, announced that it will execute a 1‑for‑15 reverse stock split. The decision was made by the Board of Directors after consultation with external legal and financial advisors. The reverse split is intended to preserve the company’s Nasdaq listing and to provide greater flexibility for future growth initiatives.
Key Details of the Reverse Split
| Item | Information |
|---|---|
| Effective Date | 12:01 a.m. Eastern Time, December 26, 2025 |
| Trading Adjusted Basis | Shares will trade on the Nasdaq on the day of the split as “ASRT” under a new CUSIP number, 04546C 304 |
| Ratio | One share for every fifteen shares previously outstanding |
| Rationale | Maintaining Nasdaq listing; enabling the company to build momentum around its core growth driver, Rolvedon; supporting progress toward becoming a sustainable, commercially focused organization |
Background and Strategic Context
Assertio’s primary product lines include oral suspension, suppositories, tablets, nasal spray, and capsules, all marketed to U.S. consumers. The company’s market capitalization stands at approximately $69 million (USD), with a 52‑week high of $1.01 and a 52‑week low of $0.51. As of December 18, 2025, the closing price was $0.72. The reverse split will consolidate the share count, potentially improving the per‑share price and aligning the company’s market metrics with Nasdaq’s listing requirements.
CEO Mark Reisenauer explained that the reverse split is the most effective option among alternatives considered. He emphasized that the action will provide the flexibility needed to capitalize on the momentum generated by Rolvedon, the company’s primary growth catalyst. The Board believes that the split will also aid Assertio in achieving a commercially sustainable model and delivering long‑term value to shareholders.
Timeline of Announcements
- December 19, 2025 – Assertio filed a Certificate of Amendment to its certificate of incorporation to implement the reverse split.
- December 22, 2025 (21:32 UTC) – Official announcement on WallStreet-Online.de, confirming the effective date and new CUSIP.
- December 22, 2025 (21:42 UTC) – Investing.com reported the impending split scheduled for December 26.
- December 22, 2025 (21:48 UTC) – SeekingAlpha confirmed the 1‑for‑15 reverse stock split.
Implications for Shareholders
Upon completion of the reverse split, each shareholder will possess one‑fifteenth of the number of shares held prior to the split. The company’s common stock will continue to trade on the Nasdaq under the same ticker, ASRT. Shareholders should note that the adjusted share count and price will reflect the consolidation, and the market may experience a revaluation as a result.
